Figure 10.(A) Nomogram established for prognosis of PAAD. (B) Calibration curves for 1- and 3-year survival of PAAD. (C) Chemosensitivity of NDC1 in PAAD.
Figure 10 — Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer | Aging
